Literature DB >> 32514863

Increased Oxidative Stress Toxicity and Lowered Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis: Associations with Psychiatric Comorbidities.

Michael Maes1,2,3, Thitiporn Supasitthumrong1, Chusak Limotai4, Ana Paula Michelin5, Andressa Keiko Matsumoto5, Laura de Oliveira Semão5, João Victor de Lima Pedrão5, Estefânia Gastaldello Moreira5, Andre F Carvalho6,7, Sunee Sirivichayakul8, Décio Sabbatini Barbosa5, Buranee Kanchanatawan9.   

Abstract

Oxidative stress toxicity (OSTOX), as well as lowered antioxidant defenses (ANTIOX), plays a role in temporal lobe epilepsy (TLE). Nevertheless, the associations between OSTOX/ANTIOX and psychiatric comorbidities in TLE are largely unknown. Thus, this study examines plasma malondialdehyde (MDA), lipid hydroperoxides (LOOH), advanced oxidation protein products (AOPP), nitric oxide metabolites (NOx), total radical-trapping antioxidant parameter (TRAP), and sulfhydryl (-SH) groups in depression due to TLE (n = 25); anxiety disorders due to TLE (n = 27); psychotic disorder due to TLE (n = 25); "pure TLE" (n = 27); and healthy controls (n = 40). TLE and mesial temporal sclerosis (MTS) were characterized by significant increases in OSTOX (MDA, AOPP, LOOH) and lowered ANTIOX (-SH groups, TRAP). The discrimination of pure TLE from controls yielded a significant area under the ROC curve for MDA (0.999), AOPP (0.851), -SH groups (0.899), and the OSTOX/ANTIOX ratio (0.996). Seizure frequency is significantly associated with increased MDA and lowered LOOH and NOx levels. Increased MDA was associated with the severity of depressive and physiosomatic symptoms, while increased AOPP levels predicted suicidal ideation. Depression and anxiety disorders co-occurring with TLE showed significantly lower MDA levels than TLE without any comorbidities. The psychotic and negative symptoms of TLE are associated with increased MDA levels and excitation with increased LOOH and lowered TRAP levels. These results indicate that oxidative stress toxicity especially protein oxidation and aldehyde formation coupled with lowered -SH groups plays a key role in the pathophysiology of TLE/MTS. Increased aldehyde formation also impacts psychopathology and psychosis, as well as negative and depressive symptoms.

Entities:  

Keywords:  Inflammation; Major depression; Neuroimmunomodulation; Neurotoxicity; Oxidative stress; Schizophrenia; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2020        PMID: 32514863     DOI: 10.1007/s12035-020-01949-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  72 in total

1.  The 2017 ILAE classification of seizure types and the epilepsies: what do people with epilepsy and their caregivers need to know?

Authors:  Martin J Brodie; Sameer M Zuberi; Ingrid E Scheffer; Robert S Fisher
Journal:  Epileptic Disord       Date:  2018-04-01       Impact factor: 1.819

2.  The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967.

Authors:  W A Hauser; L T Kurland
Journal:  Epilepsia       Date:  1975-03       Impact factor: 5.864

3.  Prevalence of psychiatric comorbidities in temporal lobe epilepsy in a Southern Brazilian population.

Authors:  José Augusto Bragatti; Carolina Machado Torres; Renata Gomes Londero; Kelin Cristine Martin; Ana Cláudia de Souza; Maria Paz Loayza Hidalgo; Márcia Lorena Fagundes Chaves; Marino Muxfeldt Bianchin
Journal:  Arq Neuropsiquiatr       Date:  2011-04       Impact factor: 1.420

4.  Psychiatric disorders in temporal lobe epilepsy: an overview from a tertiary service in Brazil.

Authors:  Guilherme Nogueira M de Oliveira; Arthur Kummer; João Vinícius Salgado; Eduardo Jardel Portela; Sílvio Roberto Sousa-Pereira; Anthony S David; Antônio Lúcio Teixeira
Journal:  Seizure       Date:  2010-08-13       Impact factor: 3.184

Review 5.  Ammon's horn sclerosis: a maldevelopmental disorder associated with temporal lobe epilepsy.

Authors:  Ingmar Blümcke; Maria Thom; Otmar D Wiestler
Journal:  Brain Pathol       Date:  2002-04       Impact factor: 6.508

6.  The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico
Journal:  Epilepsia       Date:  2010-11-10       Impact factor: 5.864

7.  The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy.

Authors:  Erica K Johnson; Jana E Jones; Michael Seidenberg; Bruce P Hermann
Journal:  Epilepsia       Date:  2004-05       Impact factor: 5.864

8.  Temporal lobe epilepsy: neuropathological and clinical correlations in 243 surgically treated patients.

Authors:  Laura Tassi; Alessandra Meroni; Francesco Deleo; Flavio Villani; Roberto Mai; Giorgio Lo Russo; Nadia Colombo; Giuliano Avanzini; Chiara Falcone; Manuela Bramerio; Alberto Citterio; Rita Garbelli; Roberto Spreafico
Journal:  Epileptic Disord       Date:  2009-11-30       Impact factor: 1.819

9.  Epilepsy, mental health disorder, or both?

Authors:  Vadim Beletsky; Seyed M Mirsattari
Journal:  Epilepsy Res Treat       Date:  2011-12-15

10.  A review of the epidemiology of temporal lobe epilepsy.

Authors:  Jose F Téllez-Zenteno; Lizbeth Hernández-Ronquillo
Journal:  Epilepsy Res Treat       Date:  2011-12-29
View more
  2 in total

1.  A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine.

Authors:  Michael Maes; Décio Sabbatini Barbosa; Abbas F Almulla; Buranee Kanchanatawan
Journal:  Antioxidants (Basel)       Date:  2022-04-20

2.  Hydroalcoholic Leaf Extract of Isatis tinctoria L. via Antioxidative and Anti-Inflammatory Effects Reduces Stress-Induced Behavioral and Cellular Disorders in Mice.

Authors:  Noemi Nicosia; Inga Kwiecień; Justyna Mazurek; Kamil Mika; Marek Bednarski; Natalizia Miceli; Salvatore Ragusa; Halina Ekiert; Michael Maes; Magdalena Kotańska
Journal:  Oxid Med Cell Longev       Date:  2022-06-25       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.